These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 16530549)

  • 1. Is NAFLD an incidentaloma?
    Tarantino G
    Gastroenterology; 2006 Mar; 130(3):1014-5. PubMed ID: 16530549
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
    Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
    Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures.
    Zelber-Sagi S; Nitzan-Kaluski D; Halpern Z; Oren R
    Liver Int; 2006 Sep; 26(7):856-63. PubMed ID: 16911469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of cardiorespiratory fitness, body mass index, and waist circumference to nonalcoholic fatty liver disease.
    Church TS; Kuk JL; Ross R; Priest EL; Biltoft E; Blair SN
    Gastroenterology; 2006 Jun; 130(7):2023-30. PubMed ID: 16762625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Non-alcoholic fatty liver].
    Zwimpfer J
    Praxis (Bern 1994); 2000 Oct; 89(43):1757-8. PubMed ID: 11103621
    [No Abstract]   [Full Text] [Related]  

  • 7. [When should liver biopsy be considered? Slightly increased ALAT can indicate steatosis--but a histological test is necessary for prognosis].
    Danielsson A
    Lakartidningen; 2004 Sep; 101(38):2862. PubMed ID: 15485168
    [No Abstract]   [Full Text] [Related]  

  • 8. Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future.
    Wieckowska A; McCullough AJ; Feldstein AE
    Hepatology; 2007 Aug; 46(2):582-9. PubMed ID: 17661414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
    Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are non-invasive tests accurate enough to predict hepatic fibrosis in non-alcoholic fatty liver disease (NAFLD)?
    Chavez-Tapia NC; Tiribelli C
    Gut; 2008 Oct; 57(10):1351-3. PubMed ID: 18791116
    [No Abstract]   [Full Text] [Related]  

  • 11. Defining nonalcoholic fatty liver disease: implications for epidemiologic studies.
    Clark JM; Diehl AM
    Gastroenterology; 2003 Jan; 124(1):248-50. PubMed ID: 12512048
    [No Abstract]   [Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease: from clinical recognition to treatment.
    Sevastianos VA; Hadziyannis SJ
    Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):59-79. PubMed ID: 19072371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological study of nonalcoholic fatty liver disease in Japan: the risk factors for fibrosis.
    Miyaaki H; Ichikawa T; Nakao K; Yatsuhashi H; Furukawa R; Ohba K; Omagari K; Kusumoto Y; Yanagi K; Inoue O; Kinoshita N; Ishibashi H; Yano M; Eguchi K
    Liver Int; 2008 Apr; 28(4):519-24. PubMed ID: 17976158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study.
    Adams LA; Waters OR; Knuiman MW; Elliott RR; Olynyk JK
    Am J Gastroenterol; 2009 Apr; 104(4):861-7. PubMed ID: 19293782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Steatosis of the liver. Biopsy cases].
    Petersen P
    Ugeskr Laeger; 1967 Aug; 129(31):988-90. PubMed ID: 5626248
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationships between estimates of adiposity, insulin resistance, and nonalcoholic fatty liver disease in a large group of nondiabetic Korean adults.
    Sung KC; Ryan MC; Kim BS; Cho YK; Kim BI; Reaven GM
    Diabetes Care; 2007 Aug; 30(8):2113-8. PubMed ID: 17475935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
    Prashanth M; Ganesh HK; Vima MV; John M; Bandgar T; Joshi SR; Shah SR; Rathi PM; Joshi AS; Thakkar H; Menon PS; Shah NS
    J Assoc Physicians India; 2009 Mar; 57():205-10. PubMed ID: 19588648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver enzymes and histology in obese patients with obstructive sleep apnea.
    Kallwitz ER; Herdegen J; Madura J; Jakate S; Cotler SJ
    J Clin Gastroenterol; 2007; 41(10):918-21. PubMed ID: 18090161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease.
    Hjelkrem MC; Torres DM; Harrison SA
    Minerva Med; 2008 Dec; 99(6):583-93. PubMed ID: 19034256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan.
    Chen CH; Huang MH; Yang JC; Nien CK; Yang CC; Yeh YH; Yueh SK
    J Gastroenterol Hepatol; 2007 Sep; 22(9):1482-9. PubMed ID: 17716352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.